Chemistry:ATC code J
From HandWiki
Revision as of 18:24, 16 July 2022 by imported>LinuxGuru (linkage)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
See also
- Immune sera, immunoglobulins and vaccines for veterinary use are in the ATCvet group QI.
References
| 30S |
| ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50S |
| ||||||||||||||||||
| EF-G |
| ||||||||||||||||||
| |||||||||||||||||||
| Antifolates (inhibits purine metabolism, thereby inhibiting DNA and RNA synthesis) |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Topoisomerase inhibitors/ quinolones/ (inhibits DNA replication) |
| ||||||||||||||||
| Anaerobic DNA inhibitors |
| ||||||||||||||||
| RNA synthesis |
| ||||||||||||||||
| |||||||||||||||||
Antibacterials: others (J01X) | |
|---|---|
| Other/ungrouped |
|
| Wall/ membrane |
| ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracellular |
| ||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||
| |||||||||||||||||||||||
| Nucleic acid inhibitor |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein synthesis inhibitor |
| ||||||||
| Cell envelope antibiotic |
| ||||||||
| Other/unknown | |||||||||
| Combinations | |||||||||
| |||||||||
| Baltimore I |
| ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hepatitis B (VII) | |||||||||||||||||||||
| Multiple/general |
| ||||||||||||||||||||
| |||||||||||||||||||||
| Hepatitis C |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Picornavirus | |||||||||
| Anti-influenza agents | |||||||||
| Multiple/general |
| ||||||||
| |||||||||
| Entry/fusion inhibitors (Discovery and development) |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Reverse-transcriptase inhibitors (RTIs) |
| ||||||||||
| Integrase inhibitors (Integrase strand transfer inhibitors (INSTI)) | |||||||||||
| Maturation inhibitors | |||||||||||
| Protease Inhibitors (PI) (Discovery and development) |
| ||||||||||
| Combined formulations |
| ||||||||||
| Pharmacokinetic boosters | |||||||||||
| Experimental agents |
| ||||||||||
| |||||||||||
Immune sera and immunoglobulins (J06) | |||||
|---|---|---|---|---|---|
| Polyclonal antibodies |
| ||||
| Monoclonal antibodies | |||||
| Development | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Classes | |||||||||||
| Administration | |||||||||||
| Vaccines |
| ||||||||||
| Controversy | |||||||||||
| Related | |||||||||||
| |||||||||||
 | 0.00  (0 votes) |
